Загрузка...
Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor for cervical cancer. Given the substantial disease and death associated with HPV and cervical cancer, development of a prophylactic HPV vaccine is a public health priority. We evaluated the cost-effectiven...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Centers for Disease Control and Prevention
2003
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2873748/ https://ncbi.nlm.nih.gov/pubmed/12533280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid0901.020168 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|